scispace - formally typeset
I

Ie Ming Shih

Researcher at Johns Hopkins University

Publications -  401
Citations -  40438

Ie Ming Shih is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Ovarian cancer & Serous fluid. The author has an hindex of 97, co-authored 378 publications receiving 35329 citations. Previous affiliations of Ie Ming Shih include Howard Hughes Medical Institute & MedStar Washington Hospital Center.

Papers
More filters
Journal ArticleDOI

Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase

TL;DR: Results suggest that overexpression of Rsf-1, cyclin E and FASN occurs early in tumor progression, which is fundamental in understanding the molecular pathogenesis of high-grade serous carcinomas.
Journal ArticleDOI

Molecular basis of gestational trophoblastic diseases.

TL;DR: This review will focus on advances with special emphasis on the pathogenesis of each specific form of GTD, which includes complete and partial hydatidiform mole, invasive mole, choriocarcinoma, placental site trophoblastic tumor, epithelioid trophoblast, and placental sites nodule.
Journal ArticleDOI

Human transposon insertion profiling: Analysis, visualization and identification of somatic LINE-1 insertions in ovarian cancer

TL;DR: A strategy to amplify and sequence long interspersed element-1 (LINE-1, L1) retrotransposon insertions selectively in the human genome, transposon insertion profiling by next-generation sequencing (TIPseq), and the development of a machine-learning–based computational pipeline, TIPseqHunter, to identify insertion sites with high precision and reliability.
Journal ArticleDOI

Role of Growth Factors and Their Receptors in the Development and Progression of Melanoma

TL;DR: Studies on autocrine and paracrine roles of growth factors in melanoma development and progression will require models that can account for the complex interactions between normal and malignant cells.